Tag
FDA approvals
-
Breaking Down the Latest Eli Lilly Updates: What Investors, Patients, and Scientists Need to Know
At the heart of the conversation lies Lilly’s dual-front approach: expanding its obesity portfolio while navigating the complexities of insulin pricing and...
-
The latest news about Abbott: What’s Driving the Pharma Giant’s 2024 Shift?
What’s driving this shift? Partly, it’s the relentless pressure of competition. Thermo Fisher Scientific and Siemens Healthineers have been pushing Abbott to...
-
How Abbott’s Latest Moves Reshape Healthcare, Tech, and Global Markets
What makes Abbott’s trajectory particularly fascinating is its dual role: a legacy pharmaceutical giant evolving into a tech-forward innovator. While...